000			01856 a2200493 4500
005			20250516031436.0
264		0	_c20110808
008			201108s 0 0 eng d
022			_a1873-2518
024	7		_a10.1016/j.vaccine.2011.03.029 _2doi
040			_aNLM _beng _cNLM
100	1		_aForrest, Bruce D
245	0	0	_aA prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. _h[electronic resource]
260			_bVaccine _cMay 2011
300			_a3633-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aDrug Evaluation
650	0	4	_aFemale
650	0	4	_aHemagglutination Inhibition Tests
650	0	4	_aHumans
650	0	4	_aImmunity, Cellular
650	0	4	_aInfluenza A virus _ximmunology
650	0	4	_aInfluenza B virus _ximmunology
650	0	4	_aInfluenza Vaccines _xadministration & dosage
650	0	4	_aInfluenza, Human _xprevention & control
650	0	4	_aInterferon-gamma _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aSouth Africa
650	0	4	_aVaccination _xadverse effects
650	0	4	_aVaccines, Attenuated _xadministration & dosage
650	0	4	_aVaccines, Inactivated _xadministration & dosage
700	1		_aSteele, A Duncan
700	1		_aHiemstra, Louis
700	1		_aRappaport, Ruth
700	1		_aAmbrose, Christopher S
700	1		_aGruber, William C
773	0		_tVaccine _gvol. 29 _gno. 20 _gp. 3633-9
856	4	0	_uhttps://doi.org/10.1016/j.vaccine.2011.03.029 _zAvailable from publisher's website
999			_c20709555 _d20709555